A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)
Clinical trial NCT04887857 · COMPLETED
Trial details
- NCT number
- NCT04887857
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2024-01-08
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.